|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|---|
| Assets: | |||||
| Current assets: | |||||
| Related party receivable | |||||
| Prepaid expenses | |||||
| Prepaid insurance | |||||
| Total Current Assets | |||||
| Non-current Assets | |||||
| Investments held in Trust Account | |||||
| Deferred offering costs | |||||
| Total Assets | |||||
| Liabilities, Ordinary shares subject to possible redemption and Shareholders’ Deficit | |||||
| Current Liabilities | |||||
| Accrued expenses | |||||
| Accrued offering costs | |||||
| Due to Sponsors | |||||
| Promissory note – related party | |||||
| Related Party | |||||
| Total promissory note – related party | |||||
| Total Current Liabilities | |||||
| Deferred underwriting fee payable | |||||
| Total Liabilities | |||||
| Ordinary shares subject to possible redemption, 14,500,000 at a redemption value of $10.34 and $10.07 per share as of September 30, 2026 and December 31, 2025, respectively | |||||
| Shareholders’ Deficit | |||||
| Ordinary shares, value | |||||
| Class A Ordinary Shares | |||||
| Class B Ordinary Shares | |||||
| Additional paid-in capital | |||||
| Accumulated deficit | |||||
| Total Shareholders’ Deficit | |||||
| Total Liabilities, Ordinary shares subject to possible redemption and Shareholders’ Deficit |
Loading...